We invite you to the attend the Novel Immunotherapeutics Summit,
which will take place Jaunary 30 - 31, 2014 in San Diego, CA.
The summit will bring together our usual balance of industry and
academia, so that delegates have the unique opportunity to network with
colleagues from different sectors and gain fresh perspective on the
various research happening.
The Summit will begin with a plenary keynote session, and then break into four
concurrent conferences, all of which will talk about complementary areas of the
latest breakthroughs in the immunology field:
12th Cytokines & Inflammation
provides a forum for researchers to discuss the latest advances in targeting
cytokines and chemokines for therapeutic interventions, cytokines and
metabolism, and cytokines signaling pathways.
6th Immunotherapeutics & Immunomonitoring
will cover recent advances in immunotherapy and how they relate to various
immunotherapy modalities, specific cancers, cell subsets, animal models, and
2nd Immunogenicity and Immunotoxicity
about ongoing research for tools to mitigate risks associated with the
immunogenicity of therapeutic proteins.
Inaugural Innate Immunity
Come to learn
about discoveries in toll like receptors, inflammasome reactions, the role
of the microbiome and non-pathogenic bacteria, and many more.
Attend the Pre-Summit Workshop on January 29, 2014!**
Novel Immunoassays Workshop - Platform & Methods
This pre-summit workshop will be a time for researchers and scientists who are
interested in learning how to develop a reliable solid phase immunoassay
(such as PK and ADA assays) to support biological drug development.
Registration Required for Workshop.
We hope to see you there!
The 2014 Advisory
What past delegates said:
"Energizing and inspiring conference. The new ideas and connections are worth
- Francisco Leon, Vice President, Janssen R&D
"The GTC Meeting provided a unique opportunity for a select group of scientists
from biotechnology, pharmaceutical companies and academia to communicate and
interact in a very pleasant setting. The program covered not only fundamental
advances, but also translational and diagnostic applications of the latest
- Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation,
Cancer and Inflammation Program, NCI, NIH
"The GTC Novel Immunotherapeutics Summit was a great opportunity to meet
industry and academic leaders. The networking opportunities were ideal for
meaningful exchanges and setting up potential collaborations. "
- Yoav Peretz Ph.D., Principal Scientist, ImmuneCarta Services
"The GTC conference definitely provided a private, common, and friendly setting
to exchange ideas and opinions with industry and academia leaders. Networking
really happens at this conference with relevant and exciting topics. I left the
GTC conference with fresh ideas and with new connections for future
- Mario Pulido, USC
Jules A. Hoffmann
Joost J. Oppenheim
BECOME A SPONSOR
GTC offers comprehensive sponsorship packages for all our
meetings, including presentation opportunities, exhibit and booth space, as
well as the event delegate list. All our packages can be customized to meet
your company's budget. For more information, please contact:
Amber Kempf at
+1 (626) 256-6405 x110 or